Insider Sell: CymaBay Therapeutics Inc President of R&D Charles Mcwherter Sells 18,403 Shares. Charles Mcwherter, President of R&D at CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 18,403 shares of the company on January 19, 2024, according to a recent SEC Filing. GuruFocus.com.Historical daily share price chart and data for CymaBay Therapeutics since 2014 adjusted for splits and dividends. The latest closing stock price for ...CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The …Feb 1, 2024 · CymaBay Therapeutics, Inc. (NASDAQ:CBAY - Get Free Report) was the recipient of unusually large opti... CymaBay Therapeutics to Participate in Upcoming Investment Conferences CymaBay Therapeutics, Inc. today announced that members of its management team will participate in t...Cymabay Therapeutics (CBAY) Stock Price Performance. Cymabay Therapeutics (CBAY) Stock Key Data ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.Read more about CBAY stock here. ... In addition, it also sold pre-funded warrants to purchase 2,142,857 shares of common stock in the offering, at a public price of $6.9999 per underlying share ...View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN.Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.The average twelve-month price prediction for CymaBay Therapeutics is $23.70 with a high price target of $34.00 and a low price target of $12.00. Learn more …What's Happening With CBAY Stock Today? CymaBay Therapeutics Inc (CBAY) stock is trading at $24.65 as of 11:40 AM on Thursday, Dec 28, a gain of $0.18, or 0.74% from the previous closing price of $24.47. The stock has traded between $24.40 and $25.33 so far today. Volume today is light.Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. apple; wise; Select a currency. USD. …Feb 15, 2024 · (CBAY Quick Quote CBAY - Free Report) , for $32.50 per share in cash or a total equity value of $4.3 billion. Shares of CBAY surged on the acquisition news as the offer price represents 27% of the ... CBAY stock data, price, and news. View CBAY insider trading, corporate lobbying, Congressional trading, social media sentiment, and more.CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... Jan 30, 2024 · Headquarters. CymaBay Therapeutics 7575 Gateway Blvd Suite 110 Newark, CA 94560 T: (510) 293-8800Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67.The CymaBay Therapeutics stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of CBAY stock is predicted to drop by -2.56% tomorrow and lose -2.59% in the next 7 days. CymaBay Therapeutics Inc (CBAY:NSQ) set a new 52-week high during today's trading session when it reached 32.26. Over this period, the share price is up 300.87% ...Feb 13, 2024 · Health Care Sector Update for 02/12/2024: GILD, CBAY, IONM, TTOO February 12, 2024 — 01:51 pm EST Written by MT Newswires for MTNewswires ->Feb 18, 2024 · Summary of all time highs, changes and price drops for CymaBay Therapeutics; Historical stock prices; Current Share Price: US$32.19: 52 Week High: US$32.24 CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...Get CymaBay Therapeutics Inc (CBAY.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsThe latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by HC Wainwright & Co. on Friday, December 15, 2023. The analyst firm set a price target for 28.00 expecting CBAY to ...Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67.Cymabay Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... CBAY Stock Quotes API ... Real time CymaBay Therapeutics (CBAY) stock price quote, stock graph, news & analysis. Shortly after the Monday announcement, CymaBay said that the Food and Drug Administration had accepted its application for approval of seladelpar, and that it would issue a decision in August. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. 23.65 -0.09 -0.38% Healthcare • Biotechnology • USA • NASD Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert Draw Ideas Candle - advanced Intraday …The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... Get the latest stock price, news and history of CymaBay Therapeutics Inc. Common Stock (CBAY), a biotechnology company developing treatments for neurological disorders. See …The $32.50 price represents a nearly 27% premium from CymaBay's closing price on the trading day before the deal was announced but a more than 300% boost …NEWARK, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company …The consensus price target hints at a 40.3% upside potential for CymaBay Therapeutics Inc. (CBAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. CBAY is the ticker symbol for CymaBay Therapeutics Inc., a biotech company that develops treatments for rare liver diseases. The stock price, news, analysis, and …The consensus price target hints at a 40.3% upside potential for CymaBay Therapeutics Inc. (CBAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. The Cymabay Therapeutics Inc stock price fell by -0.279% on the last day (Tuesday, 13th Feb 2024) from $32.21 to $32.12. During the last trading day the stock fluctuated 0.374% from a day low at $32.09 to a day high of $32.21. The price has risen in 6 of the last 10 days and is up by 35.81% over the past 2 weeks.Real time CymaBay Therapeutics (CBAY) stock price quote, stock graph, news & analysis.In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. CymaBay Therapeutics Inc (CBAY) 23.80 -0.02 ( -0.06% ) USD | NASDAQ | Feb 05, 13:04In 2016, MSI acquired UK-based Airwave Systems. Find the latest Cal Bay International, Inc. (CBYI) stock quote, history, news and other vital information to help you with your stock trading and ...Feb 17, 2024 · Complete CymaBay Therapeutics Inc. stock information by Barron's. View real-time CBAY stock price and news, along with industry-best analysis. Feb 12, 2024 · Feb 12 (Reuters) - Gilead Sciences (GILD.O), opens new tab has agreed to buy CymaBay Therapeutics (CBAY.O), opens new tab for $4.3 billion, gaining access to an experimental liver disease ...Find out if CymaBay Therapeutics Inc (CBAY:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the ...Discover real-time eBay Inc. Common Stock (EBAY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.Find the latest Absci Corporation (ABSI) stock quote, history, news and other vital information to help you with your stock trading and investing.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...View CymaBay Therapeutics (NASDAQ:CBAY) historical prices, past price performance, and an advanced CBAY stock chart at MarketBeat.Dec 28, 2023 ... CymaBay Therapeutics (CBAY) is sprinting to the finish line with a breakthrough treatment for a serious liver disease. And it's pushing CBAY ...Complete CymaBay Therapeutics Inc. stock information by Barron's. View real-time CBAY stock price and news, along with industry-best analysis.The average one-year price target for Cymabay Therapeutics (NASDAQ:CBAY) has been revised to 18.28 / share. This is an increase of 17.10% from the prior estimate of 15.61 dated August 1, 2023.CymaBay Therapeutics (CBAY) (Delayed Data from NSDQ) $32.18 USD -0.02 (-0.06%) Updated Feb 16, 2024 04:00 PM ET After-Market: $32.18 0.00 (0.00%) 7:58 …Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...You can buy or sell CBAY and other ETFs, options, and stocks. View the real-time CBAY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd ... You can buy or sell CBAY and other ETFs, options, and stocks. View the real-time CBAY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd ... CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...Feb 12, 2024 ... ... CBAY stock via a tender offer. That's a 27% premium compared to the stock's closing price last Friday. Gilead Sciences is acquiring CymaBay ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...22 hours ago · CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) hit a new 52-week high on Friday .The company traded as high as $32.25 and last traded at $32.25, with a volume of 393580 shares ...1 day ago · If yes, then on this page you will find useful information about the dynamics of the CBAY stock price in 2022-2027. Is CBAY a good long term stock? When should I take profit in Cymabay Therapeutics stock? Buy or sell stock? Will CBAY stock price go up? What are analysts’ forecasts for CBAY stock? Forecst.com predicts future values using ...CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... The consensus price target hints at a 40.3% upside potential for CymaBay Therapeutics Inc. (CBAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.CymaBay Therapeutics Inc (CBAY) Stock Price & News - Google Finance Home CBAY • NASDAQ CymaBay Therapeutics Inc Follow Share $32.18 After Hours: $32.13 (0.15%) -0.048 Closed: Feb 16, 4:54:20 PM... Feb 14, 2024 ... MEGA BREAKOUT : CBAY STOCK ANALYSIS | CYMABAY THERAPEUTICS STOCK. 17 ... Price Action Trading like a Pro - I share my best tips after 14 years.Feb 14, 2024 ... MEGA BREAKOUT : CBAY STOCK ANALYSIS | CYMABAY THERAPEUTICS STOCK. 17 ... Price Action Trading like a Pro - I share my best tips after 14 years.2 days ago · Analyst Forecast. According to 14 analysts, the average rating for CBAY stock is "Hold." The 12-month stock price forecast is $27.33, which is a decrease of -15.20% from the latest price. CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67.CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The company’s shares closed last Monday at $32.21 ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...Feb 16, 2024 · Their CBAY share price targets range from $12.00 to $32.50. On average, they predict the company's share price to reach $26.15 in the next year. This suggests that the stock has a possible downside of 18.7%. View analysts price targets for CBAY or view top-rated stocks among Wall Street analysts. Find the latest CBAY240216C00034000 (CBAY240216C00034000) stock quote, history, news and other vital information to help you with your stock trading and investing.Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC Filing. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.17.62. 17.62. 6,577,800. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for CBAY stock on Yahoo Finance. View daily, weekly or monthly formats back to when CymaBay Therapeutics, Inc. stock was issued.Insider Sell: CymaBay Therapeutics Inc President of R&D Charles Mcwherter Sells 18,403 Shares. Charles Mcwherter, President of R&D at CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 18,403 shares of the company on January 19, 2024, according to a recent SEC Filing. GuruFocus.com.CBAY - CymaBay Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS) ... CymaBay Therapeutics, Inc. (US:CBAY) has 420 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 132,650,878 shares.Stock Price Forecast. The 10 analysts with 12-month price forecasts for CBAY stock have an average target of 24.1, with a low estimate of 15 and a high estimate of 34. The average target predicts a decrease of …Nov 14, 2023 · This strengthens the case for CBAY’s potential in the rapidly expanding PBC therapeutics market. In another report released today, Piper Sandler also maintained a Buy rating on the stock with a ...
CymaBay Therapeutics Inc (CBAY) Stock Price & News - Google Finance Home CBAY • NASDAQ CymaBay Therapeutics Inc Follow Share $32.18 After Hours: $32.13 (0.15%) -0.048 Closed: Feb 16, 4:54:20 PM... . Digital picture frame near me
Find the latest Centerra Gold Inc. (CGAU) stock quote, history, news and other vital information to help you with your stock trading and investing.CBAY enters Uptrend as Momentum indicator ascends above 0 level This indicator may be signaling that CBAY's price has momentum to move higher, since its current price …Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. What this means: CymaBay Therapeutics Inc. (CBAY) gets an Overall Rank of 68, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. CymaBay Therapeutics Inc. (CBAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price on Friday. Gilead Sciences is acquiring ...CBAY CymaBay Therapeutics, Inc.Stock Price & Overview. 7.36K followers. $32.19 -0.01 ( -0.03%) 4:00 PM 02/21/24. NASDAQ | $USD | Post-Market: $32.16 -0.03 ( …Stock Data. Quote · Charts · Historical Data · Analyst Coverage. Charting. CymaBay Therapeutics Inc. Nasdaq Global Select: CBAY. Events. Earnings. Dividends.Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.5 days ago · Get CymaBay Therapeutics Inc (CBAY.PH) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsStock Price Statistics The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.Aug 18, 2020 · Find the latest CymaBay Therapeutics, Inc. (CBAY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ... Nasdaq 15,580.87-49.91 ...Sep 15, 2019 · Get the latest CymaBay Therapeutics Inc. (CBAY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...1 day ago · If yes, then on this page you will find useful information about the dynamics of the CBAY stock price in 2022-2027. Is CBAY a good long term stock? When should I take profit in Cymabay Therapeutics stock? Buy or sell stock? Will CBAY stock price go up? What are analysts’ forecasts for CBAY stock? Forecst.com predicts future values using ...In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on CymaBay Therapeutics ( CBAY – Research Report ), with a price target of $33.00. The company’s shares ...Jan 30, 2024 · Headquarters. CymaBay Therapeutics 7575 Gateway Blvd Suite 110 Newark, CA 94560 T: (510) 293-8800.
Popular Topics
Tyson fury wife | Mar 9, 2021 · The CymaBay Therapeutics, Inc. stock price is closed at $ 23.09 with a total market cap valuation of $ 2.62B ( 113.40M shares outstanding). The CymaBay Therapeutics, Inc. is trading on NASDAQ with the sign CBAY. CymaBay Therapeutics, Inc. price is up 3.92% in the past 24 hours. The CymaBay Therapeutics, Inc. stock price prediction is …Jan 29, 2024 · Analyst Price Target for CBAY i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).CBAY is a clinical-stage biopharmaceutical company that develops therapies for liver and other chronic diseases. The stock price, quote, news and analysis of CBAY are updated daily on this web page. …...
Lcps careers | MoonLake Immunotherapeutics. 63.19. +1.94. +3.17%. Get CymaBay Therapeutics Inc (CBAY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The average twelve-month price prediction for CymaBay Therapeutics is $26.73 with a high price target of $32.50 and a low price target of $12.00. Learn more on ...CymaBay Therapeutics (CBAY) (Delayed Data from NSDQ) $32.18 USD -0.02 (-0.06%) Updated Feb 16, 2024 04:00 PM ET After-Market: $32.18 0.00 (0.00%) 7:58 …...
Buy here pay here semi trucks | This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Gilead Sciences is acquiring CymaBay for its lead product candidate, seladelpar. This is a treatment in development to treat primary biliary cholangitis (PBC). Gilead Sciences …Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Dec 18, 2023 ... CymaBay Therapeutics Inc (CBAY) stock is lower by -2.32% while the S&P 500 is up 0.28% as of 9:53 AM on Monday, Dec 18. CBAY is lower by -$0.51 ......
Lust island gameplay | CBAY price to book (PB)For valuing companies that are loss-making or have lots of physical asset. Company. 11.17x. Industry. 5.88x. ... Cymabay Therapeutics 's market cap is calculated by multiplying CBAY's current stock price of $32.12 by CBAY's total outstanding shares of 113,403,353.This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price on Friday. Gilead Sciences is acquiring ......
Smart data mastercard | Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. ... Cymabay Therapeu stock (CBAY) in USD. 1 CBAY = 24 USD. 1 month. 6 months. 1 year. 5 years. Cymabay Therapeu stock performance at a glance. Check Cymabay Therapeu’s past …Find the latest Dayforce Inc. (CDAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Sep 12, 2023 · Find the latest news headlines from CymaBay Therapeutics Inc. Common Stock (CBAY) at Nasdaq.com....
Mr. bojangles | Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 19, 2023 · Read why CBAY stock is a hold. ... seven analyst firms including Piper Sandler and BTIG have reissued or assigned Buy/Outperform ratings on the stock. Price targets proffered range from $21 to $33 ... Cymabay Therapeutics Inc stock is currently priced at $32.13, with a 24-hour trading volume of 24.78M. ... Cymabay Therapeutics Inc Stock (CBAY) Financials Data Cymabay Therapeutics Inc (CBAY) Net Income 2023. CBAY net income (TTM) was -$90.10 million for the quarter ending September 30, 2023, a +14.93% increase year-over-year....